AI Market Mood: Stock Dashboard
TSHA
Fundamental
Company: Taysha Gene Therapies Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -0.03
Insider Own: 25.05%
Shs Outstand: 204.94M
Perf Week: -13.07%
Market Cap: 313.56M
Forward P/E: -
EPS next Y: -0.38
Insider Trans: 0.00%
Shs Float: 153.61M
Perf Month: -23.88%
Income: -22.77M
PEG: -
EPS next Q: -0.08
Inst Own: 69.37%
Short Float: 16.85%
Perf Quarter: -24.63%
Sales: 9.91M
P/S: 31.64
EPS this Y: 61.44%
Inst Trans: -0.66%
Short Ratio: 5.76
Perf Half Y: -32.30%
Book/sh: 0.43
P/B: 3.53
EPS next Y Percentage: -1.39%
ROA: -12.11%
Short Interest: 25.88M
Perf Year: -3.47%
Cash/sh: 0.77
P/C: 1.98
EPS next 5Y: -
ROE: -114.77%
52W Range From: 1.19
52W Range To: 4.32
Perf YTD: -11.56%
Dividend Est.: -
P/FCF: -
EPS past 5Y: -137.69%
ROI: -15.23%
52W High: -64.58%
Beta: 0.93
Dividend TTM: -
Quick Ratio: 5.51
Sales past 5Y: 129.39%
Gross Margin: 86.98%
52W Low: 28.57%
ATR (14): 0.18
Dividend Ex-Date: -
Current Ratio: 5.51
EPS Y/Y TTM: 98.69%
Oper. Margin: -831.93%
RSI (14): 34.16
Volatility W: 9.27%
Volatility M: 8.85%
Employees: 52
Debt/Eq: 0.70
Sales Y/Y TTM: -30.90%
Profit Margin: -229.67%
Recom: 1.09
Target Price: 6.59
Option/Short: Yes / Yes
LT Debt/Eq: 0.68
EPS Q/Q: 89.77%
Payout: -
Rel Volume: 0.43
Prev Close: 1.58
Sales Surprise: 2.79%
EPS Surprise: -15.34%
Sales Q/Q: -62.33%
Earnings: Nov 13 AMC
Avg Volume: 4.49M
Price: 1.53
SMA20: -14.29%
SMA50: -26.31%
SMA200: -34.94%
Trades:
Volume: 1,924,509
Change: -3.16%
Technical:
Latest News:
Needham & Company LLC Reiterates Buy Rating for Taysha Gene Therapies (NASDAQ:TSHA) somewhat bullish
TSHA
Summary: Taysha Gene Therapies received reiterations of 'buy' ratings from analysts at Needham & Company LLC and other firms, with price targets ranging from $7.00 to $9.00, indicating a potential upside of 76.32%. The company's earnings report exceeded consensus estimates, with a positive earnings per share and revenue results.
Full article2024-06-17T12:20:26Z
Hasbro Citigroup BofA Securities Weil, Gotshal & Manges Crav... - Law.com neutral
HAS
Summary: Hasbro completes a $500 million debt offering advised by Cravath, Swaine & Moore and underwriters BofA Securities and Citigroup, due 2034.
Full article2024-05-17T15:06:39Z